An Act Regarding Generic Drug Pricing
Sec. 1. 32 MRSA §13702-A, sub-§12-A is enacted to read:
Sec. 2. 32 MRSA §13742-A, sub-§1, ¶¶C and D, as enacted by PL 2007, c. 402, Pt. DD, §19, are amended to read:
Sec. 3. 32 MRSA §13742-A, sub-§1, ¶E is enacted to read:
Sec. 4. 32 MRSA §13742-A, sub-§4 is enacted to read:
Sec. 5. 32 MRSA §13800 is enacted to read:
§ 13800. Access to distributed drugs
A drug distributed in this State must be made available for sale in this State, at fair market price and without any restriction that delays access, to an eligible product developer.
This bill amends the Maine Pharmacy Act to require that a drug distributed in this State must be made available for sale in this State to a person seeking to develop an application for the approval of the drug under the Federal Food, Drug, and Cosmetic Act or the licensing of a biological product under the federal Public Health Service Act. It establishes disciplinary actions for noncompliance.